Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Evogene Ltd. Share Issue/Capital Change 2024

Jul 23, 2024

6785_rns_2024-07-23_6bd56a07-b2cc-403e-8b79-d46e7f36df5c.pdf

Share Issue/Capital Change

Open in viewer

Opens in your device viewer

הבורסה לניירות ערך תל אביב TEL AVIV STOCK EXCHANGE

July 23, 2024

444781

To: TASE Members

Dear Sir/Madam,

Re: EVOGENE LTD

According to the company's report, dated July 23, 2024, a capital consolidation will be made in the Company's shares (IL0011050551), at the open of the market on July 28, 2024, to shareholders of record as of July 25, 2024. The capital consolidation will be made in a ratio of 10:1.

In accordance with the third part of TASE rules and regulations, there will be no trading in the company's shares on July 25, 2024., which is the record date for the capital consolidation.

Sincerely

(-)

Listing companies compliance unit

THE TEL-AVIV STOCK EXCHANGE LTD

2 Ahuzat Bayit St., Tel-Aviv 6525216 Israel • POB 29060, Tel-Aviv 6129001 Israel

Tel: 972-76-8160411 • Fax: 972-3-5105379

www.tase.co.il